Parkinson's Today Blog

The Coronavirus and Parkinson’s Disease

Date
Author
Parkinson's Foundation

UPDATE 4/13/2020: Due to the evolving situation with the coronavirus, we have decided to postpone all local, in-person events through June 30. Click here to view the current status of all events.

Watch our live Q&A with our National Medical Director, Dr. Michael S. Okun, about coronavirus, Parkinson's disease and hospitalization.

Category
Tips for Daily Living

One-Man Study: Brain Cell Transplant

Date
Author
Parkinson's Foundation

Parkinson’s disease (PD) results from the death and deterioration of dopamine-producing neurons (brain cells) in an area of the brain called the substantia nigra. What if those cells could be reprogrammed to function in a healthy way? That is the promise of a stem cell therapy that is called induced pluripotent stem cells (iPSCs). If this extraordinary reprogramming capability could be harnessed ― and if the results were sustainable ― that would be a scientific game changer for treating neurological diseases, including the symptoms of Parkinson’s.

Category
Science News

Medical Cannabis Convening Findings: Top Takeaways and Guidance

Date
Author
Parkinson's Foundation

Many people with Parkinson’s disease (PD) have looked to medical cannabis (marijuana) to provide some relief to their range of non-motor and motor symptoms. However, little is known about the effects of medical cannabis for PD symptoms or their potential side effects and safety issues.

Category
Research Round Up

Parkinson’s Foundation Drives Research with New Patient Engagement Framework

Date
Author
Parkinson's Foundation

patientThe Parkinson’s Foundation makes research more efficient and effective by involving those living with Parkinson’s disease (PD) in the research process. People  living with PD are experts because they know this disease, its symptoms and how it impacts their lives.

Category
Expert Care Experience

PD and Medication: Advancing Treatment

Date
Author
Parkinson's Foundation

The second most common neurodegenerative disorder after Alzheimer’s disease, Parkinson’s disease (PD) affects approximately one million Americans. Scientists are working toward discoveries to prevent or slow the disease early on, before it affects movement. Breakthrough studies include genetic research that could lead to targeted PD therapy.

Category
Research Round Up

Isradipine Study Results Disappointing

Date
Author
Parkinson's Foundation

The prevalence of Parkinson’s disease (PD) is expected to double in the next 20 years. To date, there are no proven strategies for slowing the progression of PD. A calcium channel blocker medication used to treat hypertension called, Isradipine, has been shown to be neuroprotective in animal models of PD. Several studies of people also indicated the possibility that taking Isradipine may reduce the risk for PD.

Category
Science News

mail icon

Subscribe here to get the latest news on treatments, research and other updates.